2003
DOI: 10.1001/archotol.129.10.1098
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Topical Povidone-Iodine in Chronic Suppurative Otitis Media

Abstract: To our knowledge, this is the first study to evaluate the efficacy of PVP-I as a topical agent in the treatment of chronic suppurative otitis media. The results show that clinically, topical PVP-I is as effective as topical ciprofloxacin, with a superior advantage of having no in vitro drug resistance. Also, there is an added benefit of reduced cost of therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
38
0
1

Year Published

2005
2005
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(39 citation statements)
references
References 13 publications
0
38
0
1
Order By: Relevance
“…Povidone-iodinebased antiseptic solution has broad-spectrum action against many organisms that can colonize the middle ear -bacteria, viruses, fungi and protozoa. One randomized controlled trial demonstrated that povidone-iodine had the same efficacy as ciprofloxacin drops in resolving otorrhoea (Jaya et al, 2003). Additionally, it was shown that bacterial resistance rates were much lower for iodine solution than for ciprofloxacin (Jaya et al, 2003).…”
Section: Ototopical Antibioticsmentioning
confidence: 99%
See 1 more Smart Citation
“…Povidone-iodinebased antiseptic solution has broad-spectrum action against many organisms that can colonize the middle ear -bacteria, viruses, fungi and protozoa. One randomized controlled trial demonstrated that povidone-iodine had the same efficacy as ciprofloxacin drops in resolving otorrhoea (Jaya et al, 2003). Additionally, it was shown that bacterial resistance rates were much lower for iodine solution than for ciprofloxacin (Jaya et al, 2003).…”
Section: Ototopical Antibioticsmentioning
confidence: 99%
“…One randomized controlled trial demonstrated that povidone-iodine had the same efficacy as ciprofloxacin drops in resolving otorrhoea (Jaya et al, 2003). Additionally, it was shown that bacterial resistance rates were much lower for iodine solution than for ciprofloxacin (Jaya et al, 2003). Further large-scale studies are warranted to confirm the safety and efficacy of these topical agents in CSOM.…”
Section: Ototopical Antibioticsmentioning
confidence: 99%
“…aluminium acetate, boric acid, iodine powder, and povidone-iodine are commonly used for CSOM because of their low cost and availability [81][82][83]. Eardrops containing antimicrobial agents either with or without an anti-inflammatory component have been promoted as an effective therapy for CSOM since the 1950s [84][85][86].…”
Section: Topical Treatmentmentioning
confidence: 99%
“…Topical antibiotic ear drops have been the mainstay in the medical management of actively discharging CSOM; however, with increasing clinical usage, resistance has been reported, especially following long-term therapy [15]. Therefore, a more cost-eVective, nonantibiotic preparation with eVective antimicrobial properties but with no potential to develop drug resistance and ototoxicity would be an ideal alternative in the treatment of CSOM.…”
Section: Discussionmentioning
confidence: 99%
“…Past experiences showed that clinically, topical Povidone (polyvinyl pyrrolidone)-iodine was as eVective as topical antibiotic (ciproXoxacin) drop, with a superior advantage of having no in vitro drug resistance and a reduced cost of therapy [15]. Another important aspect of these "alternative" treatments (povidone-iodine, Lantigen B) is the ability to avoid prolonged antibiotic therapy, especially in cases of bacterial resistance, resulting in reduced costs: these treatments are capable of reducing expenditure associated with treatment of recurrent acute infection and allows achievement of substantial savings in terms of cost, time, and loss of productivity.…”
Section: Discussionmentioning
confidence: 99%